Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lindenbach

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Neuroscience and Biobehavioral Reviews|October 12, 2013
Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's diseaseDavid Lindenbach, Christopher Bishop
Behavioural Brain Research|September 12, 2018
Activation of the ventral subiculum reinvigorates behavior after failure to achieve a goal: Implications for dopaminergic modulation of motivational processesDavid Lindenbach, Jeremy K Seamans, Anthony G Phillips
Behavioural Brain Research|May 20, 2014
Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian ratCorinne Y Ostock, David Lindenbach, Adam A Goldenberg, et al.
Behavioural Brain Research|August 1, 2022
Optogenetic modulation of glutamatergic afferents from the ventral subiculum to the nucleus accumbens: Effects on dopamine function, response vigor and locomotor activityDavid Lindenbach, Giada Vacca, Soyon Ahn, et al.
The International Journal of Eating Disorders|September 24, 2025
Adverse Childhood Experiences Predict Treatment Drop Out in Adolescents and Young Adults With Eating DisordersDavid Lindenbach, Amelia Austin, Manya Singh, et al.
British Journal of Pharmacology|July 2, 2017
D-512, a novel dopamine D<sub>2/3</sub> receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian ratsDavid Lindenbach, Banibrata Das, Melissa M Conti, et al.
Journal of Neurochemistry|April 14, 2015
Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian ratNirmal Bhide, David Lindenbach, Christopher J Barnum, et al.
Child Abuse & Neglect|January 1, 2021
Capacity, confidence and training of Canadian educators and school staff to recognize and respond to sexual abuse and internet exploitation of their studentsDavid Lindenbach, Olivia Cullen, Asmita Bhattarai, et al.
Journal of Child Sexual Abuse|February 14, 2022
Confidence, Training and Challenges for Canadian Child Advocacy Center Staff When Working with Cases of Online and In-person Child Sexual ExploitationDavid Lindenbach, Gina Dimitropoulos, Asmita Bhattarai, et al.
Brain Research|September 25, 2013
Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's diseaseDavid Lindenbach, Kristin B Dupre, Karen L Eskow Jaunarajs, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Neuroscience and Biobehavioral Reviews|October 12, 2013
Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's diseaseDavid Lindenbach, Christopher Bishop
Behavioural Brain Research|September 12, 2018
Activation of the ventral subiculum reinvigorates behavior after failure to achieve a goal: Implications for dopaminergic modulation of motivational processesDavid Lindenbach, Jeremy K Seamans, Anthony G Phillips
Behavioural Brain Research|May 20, 2014
Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian ratCorinne Y Ostock, David Lindenbach, Adam A Goldenberg, et al.
Behavioural Brain Research|August 1, 2022
Optogenetic modulation of glutamatergic afferents from the ventral subiculum to the nucleus accumbens: Effects on dopamine function, response vigor and locomotor activityDavid Lindenbach, Giada Vacca, Soyon Ahn, et al.
The International Journal of Eating Disorders|September 24, 2025
Adverse Childhood Experiences Predict Treatment Drop Out in Adolescents and Young Adults With Eating DisordersDavid Lindenbach, Amelia Austin, Manya Singh, et al.
British Journal of Pharmacology|July 2, 2017
D-512, a novel dopamine D<sub>2/3</sub> receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian ratsDavid Lindenbach, Banibrata Das, Melissa M Conti, et al.
Journal of Neurochemistry|April 14, 2015
Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian ratNirmal Bhide, David Lindenbach, Christopher J Barnum, et al.
Child Abuse & Neglect|January 1, 2021
Capacity, confidence and training of Canadian educators and school staff to recognize and respond to sexual abuse and internet exploitation of their studentsDavid Lindenbach, Olivia Cullen, Asmita Bhattarai, et al.
Journal of Child Sexual Abuse|February 14, 2022
Confidence, Training and Challenges for Canadian Child Advocacy Center Staff When Working with Cases of Online and In-person Child Sexual ExploitationDavid Lindenbach, Gina Dimitropoulos, Asmita Bhattarai, et al.
Brain Research|September 25, 2013
Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's diseaseDavid Lindenbach, Kristin B Dupre, Karen L Eskow Jaunarajs, et al.
Pageof 3